Relationship between anxiety and serotonin in the ventral striatum

被引:70
作者
Schwarting, RKW
Thiel, CM
Müller, CP
Huston, JP
机构
[1] Univ Dusseldorf, Inst Physiol Psychol 1, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Ctr Biol & Med Res, D-40225 Dusseldorf, Germany
关键词
amygdala; anxiety; dopamine; emotionality; frontal cortex; hippocampus; open-field; plus-maze; serotonin; striatum;
D O I
10.1097/00001756-199804200-00013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
RATS were tested in an elevated plus-maze on two consecutive days. Based on the percentage of time spent in the open arms on the Ist day, they were divided into two subgroups with either low or high anxiety levels. A post-mortem neurochemical analysis showed that animals with high anxiety had lower ventral striatal tissue levels of 5-HT. No such differences were found for 5-HT in other brain areas or in dopamine and norepinephrine levels. The ventral striatal 5-HT levels correlated with plus-maze behavior on the 2nd but not Ist day. These data suggest that individual differences in ventral striatal 5-HT interact with plus-maze behavior, which may help to explain why serotonergic drugs can have inconsistent effects in this paradigm. (C) 1998 Rapid Science Ltd.
引用
收藏
页码:1025 / 1029
页数:5
相关论文
共 27 条
[1]  
CARTER CJ, 1979, N-S ARCH PHARMACOL, V308, P1
[2]   PARADOXICAL DIFFERENCES IN ANIMAL-MODELS OF ANXIETY AMONG THE ROMAN RAT LINES [J].
CHAOULOFF, F ;
CASTANON, N ;
MORMEDE, P .
NEUROSCIENCE LETTERS, 1994, 182 (02) :217-221
[3]  
CHARNAY Y, 1995, NEUROSCI RES COMMUN, V16, P29
[4]   USE OF THE ELEVATED PLUS-MAZE IN THE SEARCH FOR NOVEL ANXIOLYTIC AGENTS [J].
DAWSON, GR ;
TRICKLEBANK, MD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (02) :33-36
[5]   REGIONAL 5-HT ANALYSIS IN ROMAN HIGH-AVOIDANCE AND LOW-AVOIDANCE RATS FOLLOWING MAO INHIBITION [J].
DRISCOLL, P ;
DEDEK, J ;
MARTIN, JR ;
BAETTIG, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 68 (03) :373-376
[6]   Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety [J].
Duncan, GE ;
Knapp, DJ ;
Breese, GR .
BRAIN RESEARCH, 1996, 713 (1-2) :79-91
[7]   MODIFICATION OF CHLORDIAZEPOXIDES BEHAVIORAL AND NEUROCHEMICAL EFFECTS BY HANDLING AND PLUS-MAZE EXPERIENCE [J].
FILE, SE ;
ANDREWS, N ;
WU, PY ;
ZHARKOVSKY, A ;
ZANGROSSI, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 218 (01) :9-14
[8]   TRIAL 2 IN THE ELEVATED PLUS-MAZE - A DIFFERENT FORM OF FEAR [J].
FILE, SE ;
ZANGROSSI, H ;
VIANA, M ;
GRAEFF, FG .
PSYCHOPHARMACOLOGY, 1993, 111 (04) :491-494
[9]   ONE-TRIAL TOLERANCE TO THE ANXIOLYTIC EFFECTS OF CHLORDIAZEPOXIDE IN THE PLUS-MAZE [J].
FILE, SE .
PSYCHOPHARMACOLOGY, 1990, 100 (02) :281-282
[10]   Role of 5-HT in stress, anxiety, and depression [J].
Graeff, FG ;
Guimaraes, FS ;
DeAndrade, TGCS ;
Deakin, JFW .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 54 (01) :129-141